| Optical control of CRISPR/Cas9 gene editing J Hemphill, EK Borchardt, K Brown, A Asokan, A Deiters Journal of the American Chemical Society 137 (17), 5642-5645, 2015 | 305 | 2015 |
| Regulation and function of RNA pseudouridylation in human cells EK Borchardt, NM Martinez, WV Gilbert Annual review of genetics 54 (1), 309-336, 2020 | 168 | 2020 |
| The Second Messenger Cyclic Di-GMP Regulates Clostridium difficile Toxin Production by Controlling Expression of sigD RW McKee, MR Mangalea, EB Purcell, EK Borchardt, R Tamayo Journal of bacteriology 195 (22), 5174-5185, 2013 | 154 | 2013 |
| Tissue-dependent expression and translation of circular RNAs with recombinant AAV vectors in vivo RM Meganck, EK Borchardt, RMC Rivera, ML Scalabrino, JE Wilusz, ... Molecular therapy Nucleic acids 13, 89-98, 2018 | 128 | 2018 |
| Controlling mRNA stability and translation with the CRISPR endoribonuclease Csy4 EK Borchardt, LA Vandoros, M Huang, PE Lackey, WF Marzluff, A Asokan Rna 21 (11), 1921-1930, 2015 | 39 | 2015 |
| Inducing circular RNA formation using the CRISPR endoribonuclease Csy4 EK Borchardt, RM Meganck, HA Vincent, CB Ball, SBV Ramos, ... Rna 23 (5), 619-627, 2017 | 32 | 2017 |
| Methods and compositions for circular RNA molecules A Asokan, E Borchardt, R Meganck, WF Marzluff US Patent 11,718,862, 2023 | 1 | 2023 |
| Methods and compositions for circular rna molecules A Asokan, E Borchardt, R Meganck, WF Marzluff US Patent App. 18/334,530, 2024 | | 2024 |
| Methods and compositions for circular rna molecules A Asokan, E Borchardt, R Meganck, WF Marzluff US Patent App. 16/761,876, 2023 | | 2023 |
| Activatable CRISPR/CAS9 for spatial and temporal control of genome editing A Deiters, JB Hemphill, A Asokan, E Borchardt US Patent 11,214,779, 2022 | | 2022 |
| MOLECULAR APPROACHES FOR CONTROLLING RNA STABILITY E Borchardt | | 2016 |